Potential Impact of Local Anesthetics Inducing Granulocyte Arrest and Altering Immune Functions on Perioperative Outcome
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Inflammation Research
- Vol. ume 14, 1-12
- https://doi.org/10.2147/jir.s275525
Abstract
Introduction: Local anesthetics (LAs) are frequently used during anesthesia; however, they may influence granulocyte function which in turn could modify immune responses in the perioperative period. Therefore, the aim of this study was to investigate the impact of clinically used doses of bupivacaine and lidocaine on granulocyte function with regard to migration, reactive oxygen species (ROS) production, neutrophil extracellular traps (NETosis) formation, and viability. Methods: A total of 38 granulocyte-enriched samples from healthy subjects were obtained by whole blood lysis. Polymorphonuclear neutrophil (PMN) samples were incubated simultaneously with different concentrations of either bupivacaine (0.03– 3.16 mmol/L) or lidocaine (0.007– 14.21 mmol/L), or without drug (control). Live cell imaging was conducted in order to observe granulocyte chemotaxis, migration, ROS production, and NETosis. Flow cytometry was used to analyze viability and antigen expression. Results: The track length (TL) of PMNs exposed to bupivacaine concentrations of 0.16 mmol/L and above significantly decreased compared to the control. Low concentrations of lidocaine were associated with slight but significant increases in TL, whereas this changed with concentrations above 1.4 mmol/L, showing a significant decrease in TL. PMN incubated with bupivacaine concentrations of 1.58 mmol/L and above or lidocaine concentrations of at least 3.6 mmol/L showed no migration or chemotaxis at all. Time to onset of maximal ROS production and time for half-maximal NETosis decreased in a dose-dependent manner for both substances. Equipotency in NETosis induction was reached by bupivacaine (1.1 mmol/L) at significantly lower concentrations than lidocaine (7.96 mmol/L). Cell viability and oxidative burst were unaffected by LAs. Conclusion: Local anesthetics in clinically used doses ameliorate granulocyte defense mechanisms, thus indicating their potentially decisive effect during the perioperative period.Keywords
This publication has 50 references indexed in Scilit:
- The Myotoxic Effect of Bupivacaine and Ropivacaine on Myotubes in Primary Mouse Cell Culture and an Immortalized Cell LineAnesthesia & Analgesia, 2013
- Bupivacaine Induces Reactive Oxygen Species Production via Activation of the AMP-Activated Protein Kinase-Dependent PathwayPharmacology, 2011
- Local Anesthetic Effects on Human Neutrophil Priming and ActivationRegional Anesthesia & Pain Medicine, 2010
- The effect of lidocaine on in vitro adhesion and migration of equine neutrophilsVeterinary Immunology and Immunopathology, 2009
- Lidocaine Protects from Myocardial Damage due to Ischemia and Reperfusion in Mice by Its Antiapoptotic EffectsAnesthesiology, 2009
- Local Anesthetics Time-Dependently Inhibit Staphylococcus aureus Phagocytosis, Oxidative Burst and CD11b Expression by Human NeutrophilsRegional Anesthesia & Pain Medicine, 2008
- Effects of ropivacaine on human neutrophil function: comparison with bupivacaine and lidocaineEuropean Journal of Anaesthesiology, 2003
- Inhibitory effects of S‐(−) and R‐(+) bupivacaine on neutrophil functionActa Anaesthesiologica Scandinavica, 2001
- The effect of lidocaine on neutrophil CD11b/CD18 and endothelial ICAM-1 expression and IL-1β concentrations induced by hypoxia–reoxygenationEuropean Journal of Anaesthesiology, 1999
- The Clinical Pharmacology of Lidocaine as an Antiarrhythymic DrugCirculation, 1974